Neonatal intestinal physiology and failure

Seminars in Pediatric Surgery

Volumn 22, Issue 4, 2013, Pages 190-194

  Carlson, Sarah J ^a   Chang, Melissa I ^a   Nandivada, Prathima ^a   Cowan, Eileen ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Duodenum; Ileum; Intestinal failure; Intestine; Jejunum; Neonate; Parenteral nutrition; Short bowel syndrome

Indexed keywords

ELECTROLYTE; ENZYME; HISTAMINE H2 RECEPTOR ANTAGONIST; HORMONE; PLACEBO; PROTON PUMP INHIBITOR; TEDUGLUTIDE;

ANATOMICAL CONCEPTS; ARTICLE; DUODENUM; ENTEROPATHY; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; ILEUM; INTESTINAL FAILURE; INTESTINE ABSORPTION; INTESTINE FUNCTION; JEJUNUM; NEWBORN CARE; NONHUMAN; NUTRIENT; PARENTERAL NUTRITION; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

DUODENUM; ILEUM; INTESTINAL FAILURE; INTESTINE; JEJUNUM; NEONATE; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME;

HUMANS; INFANT, NEWBORN; INTESTINAL DISEASES; INTESTINE, SMALL; PARENTERAL NUTRITION;

EID: 84890020306     PISSN: 10558586     EISSN: 15329453     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2013.10.007     Document Type: Article

References (69)

1. Montgomery R.K., Mulberg A.E., Grand R.J. Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology 1999, 116(3):702-731.
2. Moxey P.C., Trier J.S. Specialized cell types in the human fetal small intestine. Anat Rec 1978, 191(3):269-285.
3. Neu J. Gastrointestinal maturation and implications for infant feeding. Early Hum Dev 2007, 83(12):767-775.
4. Caspary W.F. Physiology and pathophysiology of intestinal absorption. Am J Clin Nutr 1992, 55(suppl 1):299S-308S.
5. Deane A., Chapman M.J., Fraser R.J.L., et al. Bench-to-bedside review: the gut as an endocrine organ in the critically ill. Crit Care 2010, 14(5):228.
6. Rehfeld J.F. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides. Acta Physiol 2011, 201(4):405-411.
7. Drozdowski L., Thomson A.B.R. Intestinal hormones and growth factors: effects on the small intestine. W J Gastroenterol 2009, 15(4):385-406.
8. Lack E.E. Pathology of the Pancreas, Gallbladder, Extrahepatic Biliary Tract, and Ampullary Region 2003, Oxford University Press, New York, NY.
9. Hamosh M. Digestion in the newborn. Clin Perinatol 1996, 23(2):191-209.
10. Neu J., Koldovsky O. Nutrient absorption in the preterm neonate. Clin Perinatol 1996, 23(2):229-243.
11. Sokol R.J. Fat-soluble vitamins and their importance in patients with cholestatic liver diseases. Gastroenterol Clin North Am 1994, 23(4):673-705.
12. Argao E.A., Heubi J.E. Fat-soluble vitamin deficiency in infants and children. Curr Opin Pediatr 1993, 5(5):562-566.
13. Jeppesen P.B., Hoy C.E., Mortensen P.B. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr 2000, 54(8):632-642.
14. Meydani M., Martin K.R. Intestinal absorption of fat-soluble vitamins. Intestinal Lipid Metabolism 2000, 367-378. Kluwer academic publishers, Dordrecht/Boston/London. C.M. Mansbach, P. Tso, A. Kuksis (Eds.).
15. Khanal R.C., Nemere I. Regulation of intestinal calcium transport. Annu Rev Nutr 2008, 28:179-196.
16. Bronner F. Calcium absorption: a paradigm for mineral absorption. J Nutrition 1998, 128(5):917-920.
17. Miret S., Simpson R.J., McKie A.T. Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr 2003, 23:283-301.
18. McKie A.T., Barrow D., Latunde-Dada G.O., et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001, 291(5509):1755-1759.
19. Brannan P.G., Vergne-Marini P., Pak C.Y., et al. Magnesium absorption in the human small intestine. Results in normal subjects, patients with chronic renal disease, and patients with absorptive hypercalciuria. J Clin Invest 1976, 57(6):1412-1418.
20. +-glucose cotransporters: SLC5. Physiology (Bethesda) 2004, 19(6):370-376.
21. Hediger M.A., Romero M.F., Peng J.B., et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins-Introduction. Pflugers Arch 2004, 447(5):465-468.
22. + exchange. Annu Rev Physiol 2005, 67:411-443.
23. Russell D.W. Fifty years of advances in bile acid synthesis and metabolism. J Lipid Res 2009, 50(suppl):S120-S125.
24. Dawson P.A., Lan T., Rao A. Bile acid transporters. J Lipid Res 2009, 50(12):2340-2357.
25. Watkins J.B., Ingall D., Sczepanik P., et al. Bile salt metabolism in the newborn. N Engl J Med 1973, 288(9):431-434.
26. Boehm G., Braun W., Miro G., et al. Bile acid concentrations in serum and duodenal aspirates of healthy preterm infants: effects of gestational and postnatal age. Biol Neonate 1997, 71(4):207-214.
27. Fanaro S. Feeding intolerance in the preterm infant. Early Hum Dev 2013, [Epub ahead of print].
28. Quadros E.V. Advances in the understanding of cobalamin assimilation and metabolism. Br J Haematol 2010, 148(2):195-204.
29. Dali-Youcef N., Andres E. An update on cobalamin deficiency in adults. QJM 2009, 102(1):17028.
30. Milewski P.J., Gross E., Holbrook I., et al. Parenteral nutrition at home in management of intestinal failure. Br Med J 1980, 280(6228):1356-1357.
31. Goulet O., Ruemmele F., Lacaille F., et al. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr 2004, 38(3):250-269.
32. Wallander J., Ewald U., Lackgren G., et al. Extreme short bowel syndrome in neonates: an indication for small bowel transplantation?. Transplant Proc 1992, 24(3):1230-1235.
33. DeLegge M., Alsolaiman M.M., Barbour E., et al. Short bowel syndrome: parenteral nutrition versus intestinal transplantation. Where are we today?. Dig Dis Sci 2007, 52(4):876-892.
34. Andorsky D.J., Lund D.P., Lillehei C.W., et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr 2001, 139(1):27-33.
35. Cole C.R., Hansen N.I., Higgins R.D., et al. Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22 months. Pediatrics 2008, 122(3):e573-e582.
36. Gupte G.L., Beath S.V., Kelly D.A., et al. Current issues in the management of intestinal failure. Arch Dis Child 2006, 91(3):259-264.
37. O'Keefe S.J., Buchman A.L., Fishbein T.M., et al. Short bowel syndrome and intestinal failure: consensus definitions and overview. Clin Gastroenterol Hepatol 2006, 4(1):6-10.
38. Appleton G.V.N., Bristol J.B., Williamson R.C.N. Proximal enterectomy provides a stronger systemic stimulus to intestinal adaptation than distal enterectomy. Gut 1987, 28(suppl):165-168.
39. Chaves M., Smith M.W., Williamson R.C.N. Increased activity of digestive enzymes in ileal enterocytes adapting to proximal small bowel resection. Gut 1987, 28(8):981-987.
40. Williamson R.C.N., Chir M. Intestinal adaptation. I. Structural, functional, and cytokinetic changes. N Engl J Med 1978, 298(25):1444-1450.
41. Williamson R.C.N., Chir M. Intestinal adaptation. II. Mechanisms of control. N Engl J Med 1978, 298(26):1393-1402.
42. Sham J., Martin G., Meddlings J.B., et al. Epidermal growth factor improves nutritional outcomes in a rat model of SBS. J Pediatr Surg 2002, 37(5):765-769.
43. Drucker D.J., Erlich P., Asa S.L., et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 1996, 93(15):7911-7916.
44. Burrin D.G., Stoll B., Guan X., et al. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. Endocrinology 2005, 146(1):22-32.
45. Rhoads J.M., Argenzio R.A., Chen W., et al. l-Glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 1997, 272(5):G943-G953.
46. Mannon P.J. Peptide YY as a growth factor for intestinal epithelium. Peptides 2002, 23(2):383-388.
47. Waseem T., Duxbury M., Ito H., et al. Ghrelin ameliorates TNF-a induced anti-proliferative and pro-apoptotic effects and promotes intestinal epithelial restitution. J Am Coll Surg 2004, 199(3):16-17.
48. Luk G., Baylin S.B. Polyamines and intestinal growth-increased polyamine biosynthesis after jejunectomy. Am J Physiol 1983, 245(5):G656-G660.
49. Vanderhoof J.A., Young R.J. Enteral and parenteral nutrition in the care of patients with short-bowel syndrome. Best Prac Res Clin Gasteroenterol 2003, 17(6):997-1015.
50. Dobbins J.W., Binder H.J. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 1976, 70(6):1096-1100.
51. Bogue C.O., Murphy A.J., Gerstle J.T., et al. Risk factors, complications, and outcomes of gallstones in children: a single-center review. J Pediatr Gastroenterol Nutr 2010, 50(3):303-308.
52. Hofmann A.F., Poley J.R. Cholestyramine treatment of diarrhea associated with ileal resection. N Engl J Med 1969, 281(8):397-402.
53. Nousia-Arvanitakis S., Angelopoulou-Sakadami N., Metroliou K. Complications associated with total parenteral nutrition in infants with short bowel syndrome. Hepatogastroenterology 1992, 39(2):169-172.
54. Jeppesen P.B., Hartmann B., Hansen B.S., et al. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 1999, 45(4):559-563.
55. Jeppesen P.B., Hartmann B., Thulesen J., et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 2000, 47(3):370-376.
56. Sondheimer J.M., Sokol R.J., Narkewicz M.R., et al. Anastomotic ulceration: a late complication of ileocolonic anastomosis. J Pediatr 1995, 127(2):225-230.
57. Goulet O., Baglin-Gobet S., Talbotec C., et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg 2005, 15(2):95-101.
58. Buchman A.L. Etiology and initial management of short bowel syndrome. Gastroenterology 2006, 130(2):S5-S15.
59. Hyman P.E., Everett S.L., Harada T. Gastric acid hypersecretion in short bowel syndrome in infants: association with extent of resection and enteral feeding. J Pediatr Gastroenterol Nutr 1986, 5(2):191-197.
60. Thompson J.S., Harty R.F. Postresection hypergastrinemia correlates with malabsorption but not adaptation. J Invest Surg 1994, 7(6):469-476.
61. Kato J., Sakamoto J., Teramukai S., et al. A prospective within-patient comparison clinical trial on the effect of parenteral cimetidine for improvement of fluid secretion and electrolyte balance in patients with short bowel syndrome. Hepatogastroenterology 2004, 51(60):1742-1746.
62. Bines J.E. Intestinal failure: a new era in clinical management. J Gastroenterol Hepatol 2009, 24(suppl 3):S86-S92.
63. Leroyer C., Lasheras A., Marie V., et al. Prospective follow-up of complications related to peripherally inserted central catheters. Med Mal Infect 2013, 43(8):350-355.
64. Freund H.R. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition 1991, 7(1):1-5.
65. Driscoll D.F., Blackburn G.L. Total parenteral nutrition 1990. A review of its current status in hospitalised patients, and the need for patient-specific feeding. Drugs 1990, 40(3):346-363.
66. Fallon EM, Mitchell PD, Nehra D, et al. Neonates with short bowel syndrome: an optimistic future for parenteral nutrition independence. J Am Med Assoc Surg. in press.
67. Vantini I., Benini L., Bonfante F., et al. Survival rate and prognostic factors in patients with intestinal failure. Dig Liver Dis 2004, 36(1):46-55.
68. Jeppesen P.B., Sanguinetti E.L., Buchman A., et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 2005, 54(9):1224-1231.
69. Jeppesen P.B., Pertkiewicz M., Messing B., et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 2012, 143(6):1473-1481.